deltatrials
Completed PHASE2 INTERVENTIONAL 3-arm NCT04018612

A Study of Acetaminophen for Post Surgical Dental Pain

A Randomized, Double-Blind, Multi-Dose, Single-Site, Placebo- and Active-Controlled, Efficacy, Tolerability, Safety and Pharmacokinetic Study of Two Different Dosing Regimens of Acetaminophen in Post-Surgical Dental Pain.

Sponsor: Nevakar, Inc.

Updated 7 times since 2019 Last updated: Mar 2, 2022 Started: Apr 25, 2019 Primary completion: Jul 26, 2019 Completion: Aug 15, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Dental Pain and Pain, Postoperative, this trial is completed. The trial is conducted by Nevakar, Inc. and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Aug 2019 – ~Sep 2020 · 13 months · monthly snapshotRecruiting~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotCompleted~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Apr 2022 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Apr 2022 [monthly]

    Completed PHASE2

  5. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE2

    Status: RecruitingCompleted

Show 2 earlier versions
  1. Sep 2020 — Nov 2020 [monthly]

    Recruiting PHASE2

  2. Aug 2019 — Sep 2020 [monthly]

    Recruiting PHASE2

    First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Nevakar, Inc.
Data source: Nevakar, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .